510(k) K935307
K935307 is an FDA 510(k) premarket notification submitted by Baxter Diagnostics, Inc. for the device "DADE(R) THROMBIN-ANTITHROMBIN (TAT) COMPLEX ELISA". The FDA issued a decision of Substantially Equivalent on Nov 22, 1994. The device falls under product code DDQ (Antigen, Antiserum, Control, Antithrombin Iii), a Class II device regulated under 21 CFR 864.7060. Baxter Diagnostics, Inc. has 71 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 22, 1994
- Date Received
- Nov 2, 1993
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antigen, Antiserum, Control, Antithrombin Iii
- Device Class
- Class II
- Regulation Number
- 864.7060
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Baxter Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.